Dr. Maria Lourdes Gozali has completed her Medical degree at the University of Santo Tomas, Philippines. She finished her pediatric residency and fellowship in infectious diseases in Makati Medical Center in the Philippines. She served as a former chairman of the Department of Pediatrics of Asian Hospital and Medical Center and was also chief of the section of the Pediatric Infectious Diseases in Makati Medical Center and Asian Hopsital and Medical Center. She is an active consultant in both hospitals, as well as in St. Luke’s Medical Center Global City.

Pediatric Infectious Diseases

Stef Stienstra is a strategic and creative Consultant in Biomedical Science with a parallel career as a Commander of the reserve of the Royal Dutch Navy. For the Dutch Armed Forces he has responsibility for the counter measures in CBNRe threats and (Medical) consequence management both in a military and a civilian (terrorism) setting. He is a strategic functional specialist for “Health & Environment” of the 1-Civil-Military-Interaction Command (1-CMI) of the Dutch Armed Forces and for 2015 also in the NATO Response Force (NRF), which is in 2015 the responsibility of the 1-German-Netherlands-Corps (1-GNC). In his civil career he works internationally as Consultant or as Scientific Supervisory Board Member for several medical and biotech companies, merely involved in biodefense. He is also a Visiting Professor for Punjab University in Pakistan and Rhein-Waal University in Germany. He has completed his studies in Medicine and in Biochemistry at the University of Groningen in The Netherlands and has extensive practical experience in cell biology, immuno-hematology, biodefense and transfusion medicine. His natural business acumen and negotiation competence helps to initiate new successful businesses, often created out of unexpected combinations of technologies. His good understanding of abstract science combined with excellent skills in the communication of scientific matters to non-specialists, helps him with strategic consulting at top level management.

Zoonotic Diseases

Dr. Fekadu Abebe is a scientist at the Faculty of Medicine, University of Oslo, Norway. He obtained his PhD in immunology from the Department of Immunology and Transfusion Medicine, Ulleval University Hopsital, University of Oslo. After completion of his PhD training, he was employed as a postdoctoral fellow at the Faculty of Medicine, University of Oslo. He received his BSC (Biology) and MSc (Parasitology) from the Faculty of Natural Sciences, Addis Ababa University, Ethiopia. He has been a researcher and lecturer at Aklilu Lemma Institute of Pathobiology, Addis Ababa University for many years. Dr. Abebe`s work include plant molluscicide, epidemiology and immunology of schistosomiasis, with special emphasis on specific antibody responses and puberty-related hormones on Schistosoma mansoni worm load. Dr. Abebe`s group was the first to show the influence of dehydroepiandrosterone- sulphate (DHEAS) on Schistosoma mansoni worm load in humans. Currently, Dr. Abebe is engaged in tuberculosis research, including tuberculosis epidemiology, immunology and molecular genetics. He is leading major projects that deal with molecular genetics, epidemiology, immunodiagnosis, protective immune markers during Mycobacterium tuberculosis in human population. Dr. Abebe`s publications include cytokine profile during latent and progress tuberculosis; the Beijing genotype of Mycobacterium tuberculosis and the protective efficacy of BCG; serodiagnosis of tuberculosis; and the protective role antibody responses during Mycobacterium tuberculosis infection. Dr. Abebe`s main research interest is immunology of tuberculosis, including cell-mediated and antibody responses; immunodiagnosis, and vaccine immunology

Infectious diseases epidemiology and control, Infection and immunity, including vaccines and vaccinations, and immunodiagnosis

Dr. Linana Monica Deac working at Public Health Institute, Cluj-Napoca, Regional Public Health Center, Ro National Public Health Institute, Babes – Bolyai University – 2004 to present. 1993-2000, Head of the Transylvania Epidemiology Department ( for 12 regions) 1997 – 2004 Head of several Academic and National researches and studies for epidemiology and microbiological etiology of specific infectious diseases 2005- present : Staph and Strepto - coccical infect. , Nosocomial infections , Hand washing as preventive activity for Infect Dis., Foodborn infection, Infectious diarrhea in children, Giardioza infect in population from Transylvania, Immunization studies in Romania; Coordination of general and particular actions for prevention of Infect Dis in Ro. 2 Regional awards, for prevention activity in elderly people’s pathology ( 2010 and 2012).

Epidemiology and Public Health

Huseyin Kayadibi was born and raised in Istanbul, Turkey. He received a Degree in Medicine from the GATA School of Medicine (Turkey) in 2000. He is an Associate Professor in Medical Biochemistry at Hitit University School of Medicine, where he is the head of Medical Biochemistry. He worked at Pasarow Mass Spectrometry Laboratory, University of California Los Angeles in 2012 as a visiting scholar. He has been a co-investigator on NIH and other international projects about metabolomic, proteomic and lipidomic analysis. He is the member of EFLM Working Group Test Evaluation and IFCC Working Group Cerebrospinal Fluid Proteins. He has published more than 70 papers in peer reviewed journals. His research interests are non-invasive assessment of liver fibrosis, separation techniques and mass spectrometry.

Non-invasive assessment of liver fibrosis, separation techniques and mass spectrometry.

Refat Sadeq, Prof. and Head of Medical Microbiology and Immunology Department, Faculty of Medicine, Port said University, Egypt. He has been on microbiology field over 40 years. He has started and graduated in Zagazig Faculty of Medicine for M.Sc. and Ph.D. Then started to research articles reaching more than 80 articles, many of which have been published in international scientific journals, and he has reviewed over 150 articles on different journal sites. He is a Featured Author, for books in Medical Microbiology and Immunology for both medical students and nurses. Work from 2008-2011 as Head of Microbiology Department, Faculty of Medicine- Zagazig University. Also work as member of Egyptian scientific committee for graduation of Professor and assistant Professor in Microbiology in Egypt and some Arabic countries. He signed as Board editor of EC Microbiology Journal and Journal of Human Virology and Retrovirology. Since Oct 2014 he pointed as a Head of Microbiology and Immunology department, Faculty of Medicine, Port said University. He is very goal-oriented, assisted in building many units in his department but the favorite one was that of Virology and Molecular biology. He loves how to help junior doctors in his department to solve their scientific problems. His advice to new contributors is to take your time to get to know all the tools and to invest your energy and be sure that success will happened.

Virology and Molecular biology.

Ishwar Gilada: A medical doctor, specialized in Skin & STDs with special training in HIV management, Managing Director and Consultant in HIV/AIDS at Unison Medicare& Research Centre-India’s first private sector comprehensive HIV Care clinic; President of AIDS Society of India (a professional organization of physicians in HIV care); Secretary General of Peoples Health Org. (India). He was Secretary General of ASI from 2005-2011 and the Jt. Sec. of National AIDS Committee, Govt of India (1995-97). He was the first to raise alarm against AIDS in 1985, is known for bringing India on AIDS control map, had started India’s first AIDS Clinic-1986 and has expertise in HIV care in resource-poor settings. He had trained several doctors, nurses and social workers; he was Editor-Publisher of AIDS ASIA from 1993 to 2008. He initiated, managed, supervised, evaluated over 40 HIV/AIDS projects in India, addressed over 3700 public meetings and training programs in India and abroad, has 235 scientific papers at conferences, written chapters in books on AIDS/STDs. He was consultant for American Foundation for AIDS Research (AmFAR), World Vision, USAID; has more than 65 awards to his credit including the "Outstanding Young Person of the World" –Glasgow in 1995 and Annemarie Madison Award-Germany in 1999 in Munich, Germany where he was termed as ‘the Indian Machinegun against AIDS’.

Specialized in Skin & STDs with special training in HIV management

Dr. Guirakhoo joined GeoVax as Senior Vice President R&D in October 2015. Dr. Guirakhoo was named one of the ‘50 Most Influential People in Vaccines’ in Vaccine Nation’s 2014 list. His previous assignment was Chief Technology Officer at Vaxess Technologies, a Cambridge, MA, based biotechnology company researching thermostabilization of vaccines and biologics using silk fibroin protein. Prior to this, he served as Chief Scientific Officer at Hookipa Biotech in Vienna, Austria, developing vaccines against Cytomegalovirus and cancers based on a novel replication deficient viral vector platform. Prior to that, Dr. Guirakhoo held the position of Executive Director of External R&D at Sanofi Pasteur from 2007-20012. Before joining Sanofi Pasteur in 2007, Dr. Guirakhoo was Head of Virology Research at Acambis for 15 years. During this time, he co-invented the ChimeriVax TM -technology platform in association with St. Louis University. This platform utilizes the YF 17D vaccine virus as a vector to develop chimeric live viruses. The ChimeriVaxTM vector platform was successfully used in the development of innovative vaccines such as: a) a single dose vaccine against Japanese encephalitis (IMOJEV™), marketed in Asian countries by Sanofi, b) a single dose veterinary vaccine for the prevention of West Nile encephalitis (PREVNILE™), marketed by Merck Animal Health, and c) DENGVAXIA®, the world’s first dengue vaccine approved in Mexico and Brazil in December 2015 and marketed by Sanofi. This tetravalent vaccine represents a historic milestone for half of the world population who lives at risk of dengue. Dr. Guirakhoo has over 30 years of experience in developing vaccines against infectious diseases. Dr. Guirakhoo holds a BSc in Biology, a MSc in genetics, and a PhD in Virology from the Medical University of Vienna, Austria, and was awarded a National Research Council post-doctoral fellowship at the National Center for Disease Control and Prevention in Fort Collins, CO, from 1990-1992.

Catherine Mullié obtained a PhD in Microbiology and a PharmD at the University of Lille, France, in 1999. After a post-doc year at the Faculté de Medicine in Amiens (Laboratoire d’Immunologie, INSERM-EMI 0351), she was appointed as assistant professor at the Faculté de Pharmacie in Amiens in 2000 and joined the LG-2A (Laboratoire de Glycochimie des Antimicrobiens et des Agroressources, UMR 7378 CNRS) in 2008. She has been a member of the French Society for Microbiology since 2000. Her research is focused on the development of new antimicrobial and antimalarial drugs, with a special interest in efflux-mediated antibiotic resistance in Pseudomonas aeruginosa and Acinetobacter baumannii. She currently heads the French part of a bilateral project funded by France and Algeria (Partenariat Hubert Curien Tassili) on this topic.

development of new antimicrobial and antimalarial drugs, with a special interest in efflux-mediated antibiotic resistance in Pseudomonas aeruginosa and Acinetobacter baumannii

Professor Dr. Andy I.M. Hoepelman (26-03-1955) is Head of the Department of Infectious Diseases in the University Medical Center Utrecht in the Netherlands. Until 2016 he was also the head of the Department of Internal medicine. Since August 1st 1998, he is Professor in Medicine. Dr. Hoepelman received his medical training from the University of Utrecht, receiving his Doctorate in 1978 and his MD degree in 1980. He completed two internships at the University in 1980 and 1985 to earn his board certification as a specialist in Internal Medicine. He received his PhD in 1989. In 1991/1992 he worked at the Rockefeller University, New York (Laboratory Prof. E. Tuomanen) and at the Memorial-Sloan Kettering (Department of Infectious Diseases, Prof.dr. D. Armstrong). In 1993, he was board certified as a specialist in Infectious Diseases. He also heads the training programme in Infectious Disease for internal medicine specialists at the University Hospital Utrecht. He is author/co-author of more than 400 published articles and is a member of several professional associations. His research interests are pathogenesis and treatment of HIV and viral hepatitis. He won a bronze medal in waterpolo at the Montreal Olympics

pathogenesis, treatment of HIV and viral hepatitis

Huseyin Kayadibi was born and raised in Istanbul, Turkey. He received a Degree in Medicine from the GATA School of Medicine (Turkey) in 2000. He is an Associate Professor in Medical Biochemistry at Hitit University School of Medicine, where he is the head of Medical Biochemistry. He worked at Pasarow Mass Spectrometry Laboratory, University of California Los Angeles in 2012 as a visiting scholar. He has been a co-investigator on NIH and other international projects about metabolomic, proteomic and lipidomic analysis. He is the member of EFLM Working Group Test Evaluation and IFCC Working Group Cerebrospinal Fluid Proteins. He has published more than 70 papers in peer reviewed journals. His research interests are non-invasive assessment of liver fibrosis, separation techniques and mass spectrometry.

non-invasive assessment of liver fibrosis, separation techniques and mass spectrometry.

Refat Sadeq, Prof. and Head of Medical Microbiology and Immunology Department, Faculty of Medicine, Port said University, Egypt. He has been on microbiology field over 40 years. He has started and graduated in Zagazig Faculty of Medicine for M.Sc. and Ph.D. Then started to research articles reaching more than 80 articles, many of which have been published in international scientific journals, and he has reviewed over 150 articles on different journal sites. He is a Featured Author, for books in Medical Microbiology and Immunology for both medical students and nurses. Work from 2008-2011 as Head of Microbiology Department, Faculty of Medicine- Zagazig University. Also work as member of Egyptian scientific committee for graduation of Professor and assistant Professor in Microbiology in Egypt and some Arabic countries. He signed as Board editor of EC Microbiology Journal and Journal of Human Virology and Retrovirology. Since Oct 2014 he pointed as a Head of Microbiology and Immunology department, Faculty of Medicine, Port said University. He is very goal-oriented, assisted in building many units in his department but the favorite one was that of Virology and Molecular biology. He loves how to help junior doctors in his department to solve their scientific problems. His advice to new contributors is to take your time to get to know all the tools and to invest your energy and be sure that success will happened.

Virology and Molecular biology.

Professor Janak Kishore is Chief of Serology and Molecular Virology in the department of Microbiology, Sanjay Gandhi Post-graduate Institute of Medical Sciences, India. He was Associate Editor Indian Journal of Virology, member National Academy Medical Sciences, American societies and Fellow of JICA, Japan. His passion is on healing and minimising human sufferings; on unveiling emerging viral infections and finding aetiologies in viral epidemics and in investigating undiagnosed/missed clinical infections so that appropriate treatment is given and life is saved. Dr. Kishore taught for over 30 yrs with pioneer work on parvovirus B19, developed in-house molecular techniques and published three novel clinical associations besides finding novel oncolytic property of B19. He also worked on cytomegalovirus, enteroviral haemorrhagic conjunctivitis, rubella. Dr Kishore published over 50 papers, served as reviewer for reputed journals, organized conferences, Chaired sessions and frequently invited to speak at international conferences.

Emerging viral infections,Viral epidemics and Clinical Infectious Diseases.

Dr Ashok Kapse is consulting Pediatrician practicing in the city of Surat in the Gujrat state of India, besides owning a private pediatric hospital he is also head of the pediatric department at a prestigious Mahavir super specialty hospital. He has special interest and skill in infectious diseases. Working along with CDC Atlanta he evolved simple clinical approach for diagnosis and management of Dengue illnesses particularly in resource limited situations. Recipient of many oration awards he is a popular and sought after speaker, he has delivered hundreds of lectures on Dengue, Malaria, Typhoid and antibiotic uses across the India. He has published more than 10 articles in reputed national & international journals also has contributed chapters in prestigious books.

Dengue, Malaria, Typhoid and Antibiotics

Professor Dr. Reza Nejat (1963) is Chief of Khatam-ol-Anbia Hospital, Mashhad University of Medical Sciences, 1992-1994, Taibad City, Khorasan Province, Iran. Emergency Dept of Tehranpars General Hospital 1994-2009. Emergency Dept of Iranmehr General Hospital 1997-2000. Chief of Imam Khomeini Firuzkuh Hospital, Shahid Beheshti University of Medical Sciences, 2006-2007, Firuzkuh, Tehran Province, Iran. Directing Manager of Biotourism, Consultant to Deputy of Therapeutics, Shahid Beheshti University of Medical Sciences, 2007 to March, 2008. Member of managerial board of the committee of Health Tourism, Consultant to The Chancellor of Shahid Beheshti University of Medical Sciences in Health Tourism, March 2008-September 2008. Staff of Open Heart Surgery ICU of Day General Hospital, Tehran, Iran, June 2008-September 2009. Staff of ICU of Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran, August 2008-March 2011. Assistant Professor, Anesthesiology Dept. at Shahid Beheshti University of Medical Sciences, Tehran, Iran, March 2011 onward. Assistant Professor, Anesthesiology Dept., ICU at Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran, March 2011-April 2011. Assistant Professor, Anesthesiology Dept. at 15th Khordad Hospital, OR of plastic and reconstruction surgery, Shahid Beheshti University of Medical Sciences, Tehran, Iran, April 2011-April 2012. Assistant Professor, Anesthesiology Dept. at Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran, April 2012-January 2013. Critical Care fellowship programme at Sina Hospital, Tehran University of Medical Sciences, January 2013-July 2014. Assistant Professor, Fellowship of Critical Care Medicine (FCCM), ICU, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, July 2014-May 2015. Chief of CCM Dept., Bazarganan Hospital, Feb 2016- till now

Echocardiography, acute heart failure, stress response, sepsis and IVIG.

Nito Panganiban, Ph.D., is Professor and Interim Division Chair of Microbiology at the Tulane National Primate Research Center, Chief Scientific Officer at Peptineo, and a member of the Department of Microbiology and Immunology at the Tulane University School of Medicine. Dr. Panganiban received his PhD in Microbiology and Immunology from the University of Washington, where he carried out research on bacteriophage RNA processing in Helen Whiteley's lab. He did two years of postdoctoral work on retrovirus replication in Howard Temin's lab at the McArdle Lab for Cancer Research at the University of Wisconsin before joining the faculty at McArdle. He was then a Professor in the Department of Molecular Genetics and Microbiology at the University of New Mexico Health Sciences Center. He moved to Tulane in 2012. Past work has centered on retrovirus replication including HIV. Dr. Panganiban does research on diverse emerging RNA viruses, with emphasis on pathogenic, zoonotic RNA viruses including members of the bunya- and flavivirus families including Zika virus, Rift Valley Fever, Crimean Congo hemorrhagic fever, and hantaviruses. He is an expert in multiple facets of molecular virology and nonhuman primate models for RNA viruses, vaccines, virus-host interaction, high containment facilities, molecular biology, and genomics. In addition to his academic research and teaching, he is CSO of Peptineo (a biotech firm based in Albuquerque), and has served on numerous NIH, and additional, national committees and panels, and has served as a consultant for biotech and multi-investigator consortia.

Differential gene expression using transcriptome analysis, RNA biology, RNA viruses, emerging viruses, zoonotic viruses, host-pathogen interaction, viruses requiring high containment facilities, genomics

Dr. Montelaro is a Professor in the Department of Microbiology and Molecular Genetics of the University of Pittsburgh School of Medicine with secondary appointments in the Department of Infectious Diseases and Immunology (Graduate School or Public Health) and the Department of Medicine Division of Infectious Diseases. He serves as the Co-Director of the Center for Vaccine Research and the Scientific Director of the Peptide Synthesis Core. He received his PhD in Biochemistry in 1975 from the University of Wisconsin-Madison. His research interest is in viral immunology and vaccine development, especially as related to AIDS, emerging diseases, and biodefense.

The primary focus of the Montelaro lab is to elucidate the intricate interactions between viral pathogens and host immune responses to determine the mechanisms by with host immunity contributes to protection and disease and to serve as a basis for the development of effective vaccines. A particular interest of the lab is to develop effective strategies to overcome the challenge of natural viral antigenic variation that has evolved as a common complication to the development of effective vaccines to important viral diseases, including those related to biodefense and emerging infectious diseases. Systems currently under investigation include HIV-1 and related animal lentiviruses (SHIV, SIV, and EIAV). Studies in these systems include investigation of the nature and role of antigenic variation during infection, the development of novel assays to characterize virus-specific innate, humoral, and cellular immune responses, and the design of engineered immunogens for effective vaccination against variant strains of a particular virus. In addition to these vaccine related studies, the lab also maintains a research program to develop novel de novo antimicrobial peptides (engineered cationic amphipathic peptides, or eCAPs) that can be used to inactivate a diverse spectrum of bacteria or enveloped viruses in a prophylactic or therapeutic treatment modalities.

C. A. Guzman graduated in Medicine and become Board Certified in Medical Bacteriology in Argentina. Later, he graduated as Doctor of Medicine and Surgery and obtained his Doctorate in Microbiological Sciences (University Genoa, Italy). In 1994 he became Head of the Vaccine Group (German Research Centre for Biotechnology, Germany). In 2005 he was appointed Head of the Department of Vaccinology and Applied Microbiology (HZI), becoming later also APL-Professor at the Medical School and Member of the Centre for Individualized Infection Medicine (Hannover). His work was instrumental for developing new adjuvants and antigen delivery systems, leading to more than 200 publications.

Professor Grażyna Rydzewska M.D., PhD serves as a Head of the Department of Internal Medicine and Gastroenterology with IBD Subdivision, Central Clinical Hospital of Ministry of Interior and Administration, Warsaw, Poland. She currently serves also as a Vice-president of the Polish Society of Gastroenterology, and founding member and President of the Polish Pancreatic Club, member of coucil in International Association of Pancreatology and member of the European Pancreatic Club. She is also a professor and Director of Institute of Nursing and Obstetrics in Haculty of Medicine and Health Sciences at Jan Kochanowski University, Kielce. She has founded and currently serves as Editor-in-Chief of Gastroenterology Review, also as Editor-in-Chief of International Journal of Gastroenterology Disorders & Therapy. She is a member of editorial board in many journals in gastroenterology and internal medicine field (Nowa Klinika, Polish Gastroenterology, Medical Studies, Lekarz POZ, Gastroenterologia Praktyczna and others). During 10 years she was as Chief of Polish Medical Advisory Council on Gastroenterology (national consultant) and national representative in European Crohn and Colitis Organisation. Professor Rydzewska serves also as a member of clinical advisory boards at some pharmaceutical companies.

Professor Rydzewska main areas of interest are pancreatology, especialy signal transduction in pancreatic cells, prognosis and treatment of acute pancreatitis, treatment and prognosis in inflammatory bowel disease, and gastrointestinal endoscopy. She has published over 150 articles in peer-reviewed journals and over 10 chapters in medical textbooks.

Irene Wagner-Dobler studied biology in Munich and a PhD on an environmental issue - the vertical migration of planktonic insect larvae in lakes. Then she came as an assistant of the Scientific Director to Braunschweig at the GBF - now the HZI - and rose 1989 in the Department of Microbiology. Since they deal with topics of microbial ecology . Since 2001 Irene Wagner-Dobler is a professor at the University of Braunschweig and forwards since 2004, the working group "Microbial Communication". She has won several international research awards.

To understand the mechanisms behind the bacterial communication in detail. Then we can disrupt this radio and thus prevent the bacteria develop their pathogenic properties.

Carmen Alvarez-Dominguez has completed her Ph.D at the age of 29 years from Universidad Autonoma de Madrid and postdoctoral studies from Washington University School of Medicine on Small GTPases role in Listeria monocytogenes phagocytosis. She is the director of the Group on Genomics, Proteomics and Vaccines at the Research Institute Marqués de Valdecilla (IDIVAL) in Santander, Spain. She has published more than 29 papers in reputed journals and serving as an editorial board member of Microbes and Infection and OMICS. She also is coauthor of the patent: Immunogenic peptides against Listeria and Mycobacterium, antibodies and their uses with reference PCT/ES2007/070144.

Kathleen Hefferon received her PhD from the Department of Medical Biophysics, University of Toronto and continued her post-doctoral studies at Cornell University. Dr. Hefferon has worked on faculty at the Division of Nutritional Sciences at Cornell and has written two books on biopharmaceuticals in plants. She teaches and conducts research at both the University of Toronto and Cornell University. Kathleen has 4 patents, has edited 6 books, and has multiple research publications. Kathleen currently lives with her family near Ithaca NY.

Pietro Mastroeni received a Degree in Medicine and Surgery from the University of Messina, Italy. He moved to the University of Cambridge, UK where he completed his Ph.D before becoming a Research Fellow at Imperial College, University of London UK. He is currently a Reader in Infection and Immunity at the University of Cambridge. He has published more than 100 papers in reputed journals and serves as an editorial board member.

Recent research in his group is focused on the study of pathogenesis and immunity to bacterial infections and on the improvement of strategies to deliver vaccines to the immune system. They concurrently run a number of multidisciplinary integrated research projects. Their past research has defined the role of cytokine networks, antibodies, phagocytes, B-cells and T-cell in host resistance to bacterial infections and has unravelled many bacterial virulence genes that counteract the immune system. This work is still evolving and has already contributed to the generation of new vaccine candidates. Recently, they are focused on understanding how individual bacteria interact with host cells in vivo and how subpopulations of microbes spread and distribute in the body. This has been achieved by novel multidisciplinary research approaches that integrate information acquired at different levels spanning from individual cells to global systems. This work has opened the possibility to comprehensively study the mechanistic bases of immune control of bacterial infections, thus opening the field to novel high impact research on improved prevention measures and medical treatments to fight infection. And currently, also delving into the interactions between the host and bacterial genome highlighting which bacterial genes play a role in counteracting specific host mechanisms. This research will lead to the identification of novel targets for vaccines and drug development. We are also exploring other new areas within infection such as the interplay between microbes and autoimmune diseases and the possibility to use recombinant bacteria as anti-cancer agents. This research may have translational outcomes in the generation of tools to modulate the course of autoimmune diseases and to destroy cancer cells in vivo. Another crucial line of research that we are actively pursuing deals with the understanding of how different cellular population and cell-surface receptors co-operate for the initiation and expansion of immune responses. This research is providing clues on what is required from bacterial vaccines to be effective and is guiding the development and testing of new vaccine preparations in human and domestic animals.

A. Paulo G. Almeida is Associate Professor in Medical Entomology/ Parasitology, at the Institute of Hygiene and Tropical Medicine, Universidade Nova de Lisboa (IHMT/UNL), since 2009, where he is Director of the Unit of Medical Parasitology. He is currently a visiting professor at the ZRU, University of Pretoria. He has a Medical degree from the Classic University of Lisbon; Diploma in Tropical Medicine & Hygiene (DTM&H), Royal College of Physicians, London; MSc Medical Parasitology, University of London (LSHTM) and PhD in Medical Entomology/Parasitology, University of London (ICSTM). Researcher and teacher in Medical Entomology and Parasitology and Coordinator of the MSc in Medical Parasitology of the IHMT/UNL. Has been invited as teacher in University of Oporto, University of Algarve, Faculdade Ciências e Tecnologia/ UNL, Faculdade de Veterinária/ UTL, Instituto de Ciências Sociais e Políticas/ UTL and Faculdade de Ciências/ UL. APG Almeida is author/co-author of over 30 peer reviewed publications and 5 book chapters.

APG Almeida's main areas of interest are anti-vector (mosquito and tick) vaccines and immunity and Vector-Parasite relationships; Studies on mosquito vectors aimed at malaria, arboviruses (WNV, dengue), filariasis, vector incrimination, and epidemiology; Mosquito systematics, molecular biology, bioecological and surveillance and control studies in different ecological settings; Climate change and risk analysis of mosquito borne diseases, in collaboration with specialists on remote detection. Almeida has led various research projects in those areas, supervised several postgraduate degrees, and acted as a consultant for the Portuguese National Directorate of Health and ECDC.

Dr. Bogdan Circiumaru currently hold the position of a Consultant in Infectious Diseases at the „Matei Balş“National Institute of Infectious Diseases, in Bucharest, Romania. Qualified in 1989 at the Bucharest State University of Medicine, He obtained a Diploma in Tropical Medicine and Hygiene, and a Master of Science in Infectious Diseases from the University of London. This was followed by a PhD at the Bucharest State University of Medicine. He is an experienced clinician, with good skills in clinical infectious diseases and tropical pathology. His experience includes work under the supervision of Prof. Jon Cohen and David Mabey (London), and I also worked under the supervision of Prof. Antonella D`Arminio Monforte (Milan) with HIV/AIDS patients. He had numerous publications, especially in the infectious and Tropical Diseases. He had been awarded by the University of Bucharest with The Diploma of Excellence for the Book “Compendium of Infectious Diseases“. He also published a paper into the book: “NBC Risks (1999). Current Capabilities and Future Perspectives for Protection. NATO Science Series”.

Dr Atmaram Bandivdekar completed Ph D Degree at the age of 31 years from Mumbai University. He was Post-Doctoral and Carrier fellow at Population Council, New York. He was also the visiting scientist at UC Davis Primate Center, USA. He is the Consultant at National Institute for Research in Reproductive Health which is the premier Institute in India in the field of Reproductive Health Research. He has published more than 85 papers in peer reviewed journals and also the book and two conference proceedings. He also has six National and International awards for his scientific contributions.

Reproductive Biology, Endocrinology, Biochemistry, Virology and Immunology

Vladimir Zajac has completed his PhD. in 1982 at the Cancer Research Institute of Slovak Academy of Sciences in Bratislava (Slovakia), where he worked as the Head of Department of Cancer Genetics from 1996 to 2010. He joined the Medical Faculty of the Comenius University as Associate Professor of Genetics in 2007. He has published 74 papers mostly in reputed journals and he was editor of the book „Bacteria, viruses and parasites in AIDS process“(In Tech, 2011).

HIV/AIDS and Infectious Diseases

Dr. Ahmed G. Hegazi is working as a professor of Microbiology & Immunology at National Research Center, Dept. Zoonotic Diseases from 2004. He also has work experience as prestigious chair in Dept. of Parasitology, National Research Center. He received many awards like Senior Scientist Prize of National Research Center (1996), National Scientific Prize in Biological Sciences (1990), The Second-Best Research Paper Award from International Congress of propolis, Bones Aires, Argentina (2000) and many more. He Conducted training courses on Clinical Microbiology, National Research Center in 1979. Awarded 2 Bronze medals from “The International Innovation Fair of the Middle East”, 23th - 26th October, 2007, Kuwait. Awarded of Ghazi Wad Allah Salon Prize, 2008 and Awarded the Merit Aware of Medical Sciences, The National Research Center, 2016. He has 233 articles in national and international scientific journals. Editor in 36 journals, Referee in the 80 International Journals, Organizer of 94 International Symposium and conferences, His publications: 230 articles in national and international scientific journals, 7 books in English language and 9 books in Arabic language. He has patent No. 28335at 11/12/2017.

Microbiology & Immunology

Professor of Department of Microbiology and Immunology at Bangabandhu Sheikh Mujib Medical University in Bangladesh,strong professional with a Master of Philosophy in Medical Microbiology from Institute of Postgraduate Medicine and Research.

Flow cytometry immunophenotypic diagnosis of Lymphoma, Leukemia, Multiple myeloma, Primary immunodeficiency disordres ; Stem cell ; Cytogenetic studies; advance researches on Tuberculosis.

Dr.Nancy Hagras is currently an Assistant Professor at Pharos University in Alexandria, Egypt. She has completed her BSc in Pharmacy and Biotechnology, from German University in Cairo, Egypt in 2010. She has got her MSc and PhD degrees in Applied and Molecular Parasitology at Alexandria University, Egypt, in 2014 and 2018 respectively.

Her research interests cover several aspects across parasitology, nanotechnology and molecular biology aiming to create new diagnostic and treatment pathways in order to improve the health and well-being.

A practicing physician in the field of healthcare in the state of Kerala in India for the last 30 years

Very much interested in basic research. My interest is spread across the fever, inflammation and back pain. I am a writer. I already printed and published nine books on these subjects. I wrote hundreds of articles in various magazines. After scientific studies, we have developed 8000 affirmative cross checking questions. It can explain all queries related to fever